Monday, October 4, 2010 - 9:30 AM
17690

Liposuction of the Flanks and Abdomen During Cosmetic Abdominoplasty; Safe or Sorry?

Shannon Dale Armstrong, MD1, Keith C. Neaman, MD1, Marissa Baca, BS1, Douglas VanderWoude, MD1, and John Renucci, MD2. (1) Plastic Surgery, Grand Rapids Medical Education and Research Center, Michigan State University, 221Michigan St NE, Suite 200-A, Grand Rapids, MI 49503, (2) Plastic Surgery Associates, Grand Plaza Place, Suite 700, 220 Lyon N.W., Grand Rapids, MI 49503-2216

Purpose:  Liposuction at the time of abdominoplasty is frequently performed for a wide variety of indications. While serving as a useful adjunct, considerable debate exists with respect to its effectiveness and possible contribution to post-operative complications.   Additionally, many abdominoplasties are performed with the use of tumescence alone, a practice with potentially unrealized benefits. The purpose of this abstract is to review a consecutive series of patients undergoing a cosmetic abdominoplasty, investigating the effect of synchronous liposuction and abdominoplasty, as well as the use of tumescence alone with abdominoplasty.

Methods:  A retrospective review was conducted of 1008 consecutive patients who underwent abdominoplasty over an eleven-year time period at a six-surgeon plastic surgery practice.  Data was collected detailing patient demographics, intraoperative interventions, and post-operative course. Patients were divided based on the performance of liposuction, anatomical area of liposuction (flanks or abdominal flap), and use of tumescence. Post-operative complications were divided into major or minor complications.

Results:  Of the 1008 patients, 555 underwent liposuction of the flanks while 469 underwent liposuction of the abdominal wall at the time of abdominoplasty. Liposuction of the flanks or abdominal flap (zone II) lead to an increase risk of total complications, minor complications, seroma formation and revisions (Table 1). Major complications were not affected. Three hundred forty-nine patients received tumescent without concurrent liposuction. Tumescent use  was associated with a significant decrease in hematoma, fat necrosis and minor complications (Table 2).

Conclusion:  Tumescence of the abdominal flaps serves a protective mechanism in reducing complications, namely hematoma and fat necrosis. The exact mechanism for this risk reduction remains unknown. However, because of the significant risk reduction we recommend tumescent without liposuction as an adjunct to abdominoplasty.  Liposuction places the patient at an increased risk for post-operative complications, and while minor, inevitably lead to higher revision rates with decreased patient satisfaction. Seroma rates are markedly increased as a result of disrupted lymphatic pathways in the abdominal flap.  Furthermore, flank liposuction may also lead to an increase in dead space and extensive disruption of laterally based lymphatic channels not typically associated with an abdominoplasty alone.  Surgeons should be aware of the potential complications of performing liposuction at the time of abdominoplasty and seek measures for complication reduction and improved patient selection.

 

Table 1. Outcomes of Concomitant Abdominal or Flank Liposuction

 

Liposuction Abdomen

No Liposuction Abdomen

Liposuction Flanks

No Liposuction Flanks

Total Complications

40.1% (p=<0.001)

26.2%

30.4% (p=<0.001)

25.4%

Major Complications

26.8% (p=0.021)

18.2%

20.9% (p=0.013)

14.8%

Minor Complications

39.9% (p=<0.001)

25.0%

37.5% (p=<0.001)

25.2%

Revision Rate

42.6% (p=0.006)

30.2%

41.6% (p=<0.001)

29.1%

Infection

4.9% (p=0.185)

3.1%

1.3% (p=0.231)

2.4%

Hematoma

3.1% (p=0.551)

2.3%

4.0% (p=0.743)

3.5%

Seroma

19.0% (p=0.004)

12.2%

18.4% (p=0.004)

11.7%

Fat Necrosis

3.5% (p=0.103)

1.7%

3.2% (p=0.104)

1.5%

 

 

Table 2. Tumescent without Liposuction and Abdominoplasty Outcomes

 

Tumescent

No Tumescent

Total Complications

28.7%

34.8%

p=0.048

Major Complications

15.2%

19.8%

p=0.086

Minor Complications

26.9%

34.7%

p=0.013

Hematoma

0.9%

3.5%

p=0.011

Seroma

12.3%

17.0%

p=0.54

Infection

1.3%

2.4%

p=0.999

Fat Necrosis

0.9%

3.3%

p=0.018